These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3663475)

  • 1. Synergistic cell inactivation by cis-dichlorodiammineplatinum in combination with 1-propargyl-5-chloropyrimidin-2-one.
    Dornish JM; Pettersen EO; Oftebro R
    Br J Cancer; 1987 Sep; 56(3):273-8. PubMed ID: 3663475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation by the mitotic inhibitor NY 3170 of human cells in vitro.
    Wibe E; Oftebro R
    Br J Cancer; 1979 Aug; 40(2):222-7. PubMed ID: 475968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent cell inactivation by vincristine alone or in combination with 1-propargyl-5-chloropyrimidin-2-one.
    Wibe E
    Cancer Res; 1980 Jun; 40(6):2069-73. PubMed ID: 7371040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of cis-dichlorodiammineplatinum-induced cell inactivation by benzaldehyde.
    Dornish JM; Pettersen EO; Oftebro R; Melvik JE
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1287-93. PubMed ID: 6541584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination effects of cis-dichlorodiammineplatinum with selected metahalones, pyrimidine sulfoxides and pyrimidine sulfones on human NHIK 3025 cells in vitro.
    Dornish JM; Undheim K; Pettersen EO; Oftebro R; Laland SG
    Anticancer Drug Des; 1988 Dec; 3(3):191-8. PubMed ID: 3207466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic cell inactivation of human NHIK 3025 cells by cinnamaldehyde in combination with cis-diamminedichloroplatinum(II).
    Dornish JM; Pettersen EO; Oftebro R
    Cancer Res; 1988 Feb; 48(4):938-42. PubMed ID: 3338086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced cellular uptake of cis-dichlorodiammine-platinum by benzaldehyde.
    Dornish JM; Melvik JE; Pettersen EO
    Anticancer Res; 1986; 6(4):583-8. PubMed ID: 3752939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of cis-dichlorodiammineplatinum (II)-induced cytotoxicity by methylglyoxal.
    Dornish JM; Pettersen EO
    Anticancer Res; 1989; 9(4):1137-42. PubMed ID: 2817795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen- and temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro.
    Melvik JE; Pettersen EO
    Radiat Res; 1988 Jun; 114(3):489-99. PubMed ID: 3375438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection from cis-dichlorodiammineplatinum-induced cell inactivation by aldehydes involves cell membrane amino groups.
    Dornish JM; Pettersen EO
    Cancer Lett; 1985 Dec; 29(3):235-43. PubMed ID: 4075292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H; Drewinko B
    Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cis-dichlorodiammineplatinum(II)-induced cytotoxicity by benzaldehyde derivatives.
    Dornish JM; Pettersen EO
    Cancer Lett; 1989 Jul; 46(1):63-8. PubMed ID: 2736510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of a reactive aldehyde moiety for aldehyde-mediated protection against cis-dichlorodiammineplatinum-induced cell inactivation.
    Dornish JM; Pettersen EO
    Biochem Pharmacol; 1990 Jan; 39(2):309-18. PubMed ID: 2302256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-cycle inhibitory effects of the mitotic inhibitor NY 3170 on human cells in vitro.
    Wibe E; Oftebro R; Laland SG; Pettersen EO; Lindmo T
    Br J Cancer; 1979 Apr; 39(4):391-7. PubMed ID: 444397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of Cis-dichlorodiammineplatinum(II) (NSC-119875) at ehe cellular level.
    Drewinko B; Gottlieb JA
    Cancer Chemother Rep; 1975; 59(3):665-73. PubMed ID: 1203891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfhydryl-related reduction of the mitotic inhibition and cell inactivation induced by pyrimidine analogs.
    Nygaard ME; Dornish JM; Pettersen EO; Oftebro R
    Anticancer Drug Des; 1988 Jun; 3(1):15-24. PubMed ID: 3382505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifying effect of cinnamaldehyde and cinnamaldehyde derivatives on cell inactivation and cellular uptake of cis-diamminedichloroplatinum(II) in human NHIK 3025 cells.
    Dornish JM; Pettersen EO; Oftebro R
    Cancer Res; 1989 Jul; 49(14):3917-21. PubMed ID: 2736532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of cis-dichlorodiammineplatinum(II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro.
    Melvik JE; Dornish JM; Pettersen EO
    Br J Cancer; 1992 Aug; 66(2):260-5. PubMed ID: 1503898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro modulating effect of the reversible protein synthesis inhibitor zilascorb (2H) on cis-diamminedichloroplatinum (II)-induced cytotoxicity.
    Melvik JE; Dornish JM; Larsen RO; Børretzen B; Oftebro R; Pettersen EO
    Anticancer Res; 1992; 12(1):33-8. PubMed ID: 1567178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro.
    Jekunen AP; Christen RD; Shalinsky DR; Howell SB
    Br J Cancer; 1994 Feb; 69(2):299-306. PubMed ID: 7905279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.